NCT00540475

Brief Summary

The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry (PA-IPF) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provide better access of patients with pulmonary fibrosis in all regions of Pennsylvania to standard of care and diagnosis 3) To facilitate the translation of new therapeutic interventions from the bench to the bedside.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2007

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 3, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 8, 2007

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 11, 2018

Status Verified

October 1, 2018

Enrollment Period

10.8 years

First QC Date

October 3, 2007

Last Update Submit

October 10, 2018

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

Idiopathic Pulmonary FibrosisInterstitial Lung Disease

Outcome Measures

Primary Outcomes (1)

  • IPF Disease Course

    Monitor IPF disease course

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF)

You may qualify if:

  • IPF diagnosis
  • Sufficient testing results completed for an IPF Diagnosis (screening script)
  • Adults (age \> 18 years old)
  • Participants who read and comprehend English language

You may not qualify if:

  • Children
  • Prisoner-patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

University of Pennsylvania Health System

Philadelphia, Pennsylvania, 19104, United States

Location

Temple University

Philadelphia, Pennsylvania, 19140, United States

Location

Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease

Pittsburgh, Pennsylvania, 15213, United States

Location

The Center for Health Research at Giesinger Health System

Wilkes-Barre, Pennsylvania, 18711, United States

Location

MeSH Terms

Conditions

Idiopathic Pulmonary FibrosisLung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Pulmonary FibrosisLung DiseasesRespiratory Tract Diseases

Study Officials

  • Kevin F Gibson, MD

    Medical Director, Dorothy P. & Richard P. Simmons Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

October 3, 2007

First Posted

October 8, 2007

Study Start

September 1, 2007

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

October 11, 2018

Record last verified: 2018-10

Locations

US(5)